NICE, the health technology assessment body for England, has launched its long-awaited consultation on changes to the methods it uses to assess new technologies such as medicines, medical products and diagnostics in a bid to ensure the methods “remain cutting edge and future proof.”
Life science industry associations have welcomed the proposals, with one group saying the focus on removing significant barriers to access...








